A detailed history of Engineers Gate Manager LP transactions in Personalis, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 29,822 shares of PSNL stock, worth $181,615. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,822
Holding current value
$181,615
% of portfolio
0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.19 - $6.34 $35,488 - $189,071
29,822 New
29,822 $160,000
Q1 2023

May 15, 2023

SELL
$2.01 - $4.17 $4,460 - $9,253
-2,219 Reduced 14.64%
12,942 $35,000
Q4 2022

Feb 14, 2023

BUY
$1.78 - $3.64 $26,986 - $55,186
15,161 New
15,161 $30,000
Q2 2022

Aug 15, 2022

SELL
$3.27 - $8.76 $701,954 - $1.88 Million
-214,665 Reduced 84.18%
40,327 $139,000
Q1 2022

May 16, 2022

BUY
$7.56 - $14.3 $1.38 Million - $2.6 Million
182,158 Added 250.1%
254,992 $2.09 Million
Q4 2021

Feb 14, 2022

BUY
$12.24 - $21.25 $9,192 - $15,958
751 Added 1.04%
72,834 $1.04 Million
Q3 2021

Nov 15, 2021

BUY
$16.69 - $26.05 $382,201 - $596,545
22,900 Added 46.56%
72,083 $1.39 Million
Q2 2021

Aug 16, 2021

SELL
$18.15 - $27.75 $961,478 - $1.47 Million
-52,974 Reduced 51.86%
49,183 $1.24 Million
Q1 2021

May 17, 2021

BUY
$20.71 - $51.02 $1.84 Million - $4.53 Million
88,883 Added 669.6%
102,157 $2.51 Million
Q4 2020

Feb 16, 2021

SELL
$21.84 - $44.0 $1.36 Million - $2.74 Million
-62,285 Reduced 82.43%
13,274 $486,000
Q3 2020

Nov 16, 2020

BUY
$13.63 - $24.12 $443,765 - $785,298
32,558 Added 75.71%
75,559 $1.64 Million
Q2 2020

Aug 17, 2020

BUY
$7.65 - $14.11 $328,957 - $606,744
43,001 New
43,001 $558,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $280M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.